Equities

Electromed Inc

Electromed Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)14.62
  • Today's Change0.62 / 4.43%
  • Shares traded15.42k
  • 1 Year change+37.15%
  • Beta0.2506
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

  • Revenue in USD (TTM)53.50m
  • Net income in USD4.36m
  • Incorporated1992
  • Employees170.00
  • Location
    Electromed Inc500 6th Ave NWNEW PRAGUE 56071United StatesUSA
  • Phone+1 (952) 758-9299
  • Websitehttps://smartvest.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Xtant Medical Holdings Inc101.23m-1.66m85.31m207.00--1.7941.700.8428-0.0189-0.01890.80190.36621.291.366.06489,043.50-2.11-10.38-2.98-14.6861.4761.08-1.64-8.660.978-4.140.3638--57.504.81107.78--18.47--
Asensus Surgical Inc8.72m-78.71m91.43m207.00--7.01--10.48-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Akoya Biosciences Inc93.57m-68.01m105.19m330.00--3.21--1.12-1.47-1.471.990.66320.60562.207.08283,554.50-44.01---56.06--55.99---72.68--2.38-10.150.7013--29.09--10.36------
TELA Bio Inc63.15m-40.30m107.25m227.00--7.46--1.70-1.67-1.672.610.58340.96681.377.60278,180.60-61.70-52.00-79.77-60.9568.9765.32-63.82-107.653.23-8.520.7387--41.1347.85-5.35---17.12--
Fonar Corp102.72m10.29m107.74m561.0010.840.655.711.051.481.4814.7224.700.502319.991.41183,098.207.168.737.409.6045.5548.3314.2616.399.16--0.0051--1.083.89-24.71-15.058.48--
EUDA Health Holdings Ltd3.71m-8.44m114.52m106.00------30.90-0.3685-0.43840.1707-0.30450.2752--3.5534,966.61-62.62------22.72---227.57-----1.49-----1.54--66.17------
KORU Medical Systems Inc29.32m-13.27m116.24m82.00--6.07--3.96-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Harvard Bioscience, Inc.106.79m-8.73m120.30m391.00--1.75--1.13-0.2029-0.20292.501.580.76621.746.46273,112.50-6.26-3.29-7.60-3.8958.5256.67-8.18-4.570.9352-0.40170.341---0.9573-1.4564.11--18.10--
DIH Holding US Inc60.30m-1.77m122.85m--------2.04-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Electromed Inc53.50m4.36m126.55m170.0029.582.9724.442.370.49420.49426.084.921.173.312.25314,682.309.497.8611.039.1476.4176.258.147.385.87--0.000.0015.3811.1737.3511.0024.58--
InfuSystem Holdings Inc127.41m84.00k139.91m499.002,363.312.6811.381.100.00280.00285.912.461.2310.666.57255,330.700.08114.600.09555.6950.2756.430.06594.071.511.560.36410.0014.4413.384,744.44--6.01--
Clearpoint Neuro Inc26.16m-20.63m147.25m107.00--4.26--5.63-0.8326-0.83261.051.260.50371.2610.08244,495.30-39.71-34.75-49.90-39.6757.1064.75-78.84-76.912.61--0.2237--16.5626.64-34.40--75.30--
Stereotaxis Inc27.10m-21.22m147.93m122.00--10.09--5.46-0.2575-0.25750.32880.24390.60121.456.14222,155.70-44.08-25.02-63.05-34.1255.1667.57-73.32-41.901.79--0.00---4.89-1.82-12.33--6.63--
Trubridge Inc336.45m-50.22m167.93m3.22k--0.9064--0.4991-3.53-3.5323.6812.350.7886160.455.66104,519.70-12.051.25-13.581.4148.4550.40-15.271.561.930.92110.500245.063.913.89-387.73--88.71--
908 Devices Inc.50.73m-34.79m168.29m230.00--1.02--3.32-1.07-1.071.564.770.24861.676.48220,578.30-17.04-14.16-18.79-15.3551.1353.02-68.56-64.257.53--0.00--7.2117.89-8.45--22.98--
Data as of Jul 03 2024. Currency figures normalised to Electromed Inc's reporting currency: US Dollar USD

Institutional shareholders

26.71%Per cent of shares held by top holders
HolderShares% Held
Summers Value Partners LLCas of 14 Dec 2023550.49k6.36%
Punch & Associates Investment Management, Inc.as of 31 Mar 2024374.10k4.32%
The Vanguard Group, Inc.as of 31 Mar 2024365.31k4.22%
Dimensional Fund Advisors LPas of 31 Mar 2024270.19k3.12%
Acadian Asset Management LLCas of 31 Mar 2024214.10k2.47%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 2023126.22k1.46%
GAMCO Asset Management, Inc.as of 31 Mar 2024111.36k1.29%
Bridgeway Capital Management LLCas of 31 Mar 2024107.39k1.24%
Renaissance Technologies LLCas of 31 Mar 202498.27k1.14%
RBC Capital Markets LLC (Investment Management)as of 31 Mar 202494.36k1.09%
More ▼
Data from 28 Mar 2024 - 05 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.